SCHEMBL6090346

SCHEMBL6090346

CCCCc1ccc(-c2ccc3c(NC(=O)c4ccc(OC(C)C)cc4)c(C(=O)OCC)n(Cc4cccc(Cl)c4)c3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
TP53 P04637 4/20 0.41
SLC2A1 P11166 2/20 0.38
POLB P06746 1/20 0.38
S1PR3 Q99500 5/20 0.38
RXFP1 Q9HBX9 1/20 0.38
PPARG P37231 5/20 0.37
PPARA Q07869 3/20 0.37
CYP2C9 P11712 1/20 0.37
EGFR P00533 1/20 0.37
CHRM4 P08173 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRA2A P08913 1/20 0.37
ALOX5 P09917 1/20 0.37
ADRB3 P13945 1/20 0.37
DRD2 P14416 1/20 0.37
ADRA2B P18089 1/20 0.37
CHRM3 P20309 1/20 0.37
TACR2 P21452 1/20 0.37
DRD1 P21728 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6090079 0.93 TP53 (0.42) TP53SLC2A1POLBS1PR3PPARG
SCHEMBL6092460 0.91 RXFP1 (0.44) MAPTTP53POLBS1PR3RXFP1
SCHEMBL6091726 0.87 YWHAH (0.41) MAPTTP53SLC2A1POLBPPARG
SCHEMBL6091727 0.86 YWHAH (0.40) MAPTTP53SLC2A1POLBPPARG
SCHEMBL6091713 0.86 YWHAH (0.40) MAPTTP53SLC2A1POLBPPARG
SCHEMBL6092716 0.86 TP53 (0.42) MAPTTP53S1PR3RXFP1
SCHEMBL6091719 0.86 LMNA (0.39) MAPTSLC2A1S1PR3RXFP1PPARG
SCHEMBL6090174 0.84 TP53 (0.41) MAPTTP53POLBRXFP1
SCHEMBL6089483 0.84 TP53 (0.44) TP53SLC2A1POLBS1PR3PPARG
SCHEMBL5798590 0.84 L3MBTL1 (0.43) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160879-A1 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160879-A1 Indoles useful in the treatment of inflammation IDO1, PTGS1, IDO2 MAPT 3503/4885TP53 2032/4885SLC2A1 2589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.